Thyrotropin-releasing hormone receptor 2(TRHR-2)
AssigneeAstraZeneca Canada Inc.
InventorPhilippe Walker
Life of this patent
Estimating the term…
Abstract
The present invention is directed to the novel receptor for TRH which has been designated as TRH receptor 2. The invention encompasses both the receptor protein as well as nucleic acids encoding the protein. In addition, the present invention is directed to methods and compositions which rely upon either TRHR-2 proteins or nucleic acids.
Claims8
A substantially pure protein comprising the amino acid sequence of SEQ ID NO:2, wherein said protein comprises a receptor for thyrotropin-releasing hormone (TRH).
A substantially pure protein wherein said protein has an amino acid sequence that consists essentially of the amino acid sequence of SEQ ID No:2.
Dependencies are inferred from the claim text.